Nonsquamous non small cell lung cancer
Clinical trials for Nonsquamous non small cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new Nonsquamous non small cell lung cancer trials appear
Sign up with your email to follow new studies for Nonsquamous non small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double immunotherapy attack shows promise for tough lung cancer
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, zimberelimab and domvanalimab, as a first treatment for people with advanced non-small cell lung cancer that has high levels of a protein called PD-L1. The study includes 169 participants and aims to see if t…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase 2 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a smart drug outperform chemo for Hard-to-Treat lung cancer?
Disease control OngoingThis phase 3 trial compares an experimental drug called patritumab deruxtecan with standard platinum-based chemotherapy in people with a specific type of non-small cell lung cancer that has an EGFR mutation and has progressed after EGFR-targeted therapy. The drug is designed to d…
Matched conditions: NONSQUAMOUS NON SMALL CELL LUNG CANCER
Phase 3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC